Treatment of RSV-transformed "poorly" virogenic and non-virogenic mammalian cell lines with inhibitors of protein synthesis: failure to potentiate RSV rescue.
Treatment of the RSV-transformed "poorly" virogenic rat clones LW13-RsK4 and LW13-RsK4 R1 with cycloheximide or puromycin before fusion with chick embryo fibroblasts did not lead to RSV rescue. Neither was RSV rescued from the RSV-transformed non-virogenic mouse line RVP3 treated with 5-bromodeoxyuridine and cycloheximide or puromycin before fusion.
D001358:Avian Sarcoma Viruses / Q000187:drug effects*; D001973:Bromodeoxyuridine / Q000494:pharmacology; D002459:Cell Fusion; D002471:Cell Transformation, Neoplastic; D002478:Cells, Cultured; D003513:Cycloheximide / Q000494:pharmacology; D011691:Puromycin / Q000494:pharmacology; D014779:Virus Replication / Q000187:drug effects
D011691:Puromycin; D003513:Cycloheximide; D001973:Bromodeoxyuridine